GleamWall
中文EN

RBOT Vicarious Surgical Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1812173 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY20.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-177.5%
ROA-115.0%
ROIC (approx.)-178.7%
Asset turnover—

Leverage & solvency

Liabilities / assets49.7%
Debt / equity0.00x
Current ratio2.97x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-11.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$33.60M$40.16M
SG&A expense$15.20M$21.88M
Operating income-$50.03M-$66.56M
Pretax income-$50.18M-$63.22M
Net income-$50.18M-$63.22M
EBITDA-$48.60M-$64.45M
EPS (diluted)——
Weighted avg. shares (diluted)6.13M5.89M
Balance sheet
Cash & equivalents$2.57M$9.74M
Short-term investments$7.22M$39.36M
Current assets$11.58M$51.70M
PP&E, net$1.27M$4.48M
Total assets$19.58M$67.72M
Current liabilities$3.90M$7.67M
Total liabilities$9.74M$21.02M
Shareholders' equity$9.84M$46.70M
Cash flow statement
Operating cash flow-$45.08M-$49.96M
Capital expenditure$132,000$180,000
Free cash flow-$45.21M-$50.14M
Investing cash flow$32.15M$6.86M
Financing cash flow$5.76M$8,000
Depreciation & amortization$1.43M$2.11M
Stock-based compensation$8.13M$11.90M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.